Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting

Autor: Martin-Campos, JM, Plana, N, Figueras, R, Ibarretxe, D, Caixas, A, Esteve, E, Perez, A, Bueno, M, Mauri, M, Roig, R, Martinez, S, Pinto, X, Masana, L, Julve, J, Blanco-Vaca, F, Argimon, J, Arroyo, JA, Matas, L, Carreras, G, Anglada, J, Perea, V, Borrallo, RM, Garcia, M, Grau, J, Guerrero, C, Montaner, P, Guiterrez, L, Llargues, E, Vila, M, Sanchez, E, Morales, C, Mujal, A, Sola, J, Cano, A, Ros, E, Zambon, D, Ramirez, R, Soler, C, Vila, A, Zamora, A, Vila, L, Jerico, C

Publikováno v: Journal of Clinical Lipidology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

BACKGROUND: Autosomal dominant hypercholesterolemia (ADH) is associated with mutations in the low-density lipoprotein (LDL) receptor (LDLR), apolipoprotein B (APOB), and proprotein convertase subtilisin/kexin 9 (PCSK9) genes, and it is estimated to b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9f1299ff288e2e6a921cf7e67ded2817
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3277

Long-term exposure to PM 10 above WHO guidelines exacerbates COVID-19 severity and mortality.

Autor: Marquès M; Universitat Rovira i Virgili, Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Sant Llorenç 21, 43201 Reus, Catalonia, Spain. Electronic address: montserrat.marques@urv.cat., Correig E; Universitat Rovira i Virgili, Department of Biostatistics, Sant Llorenç 21, 43201 Reus, Catalonia, Spain., Ibarretxe D; Universitat Rovira i Virgili, LIPIDCAS, University Hospital Sant Joan IISPV, CIBERDEM, Reus, Spain., Anoro E; LIPIDCAS, Pius Hospital Valls, Valls, Spain., Antonio Arroyo J; Lipid Unit, University Hospital Santa Creu i Sant Pau, Barcelona Autonomous University, Barcelona, Spain., Jericó C; Lipid Unit, Hospital Moises Broggi. Consorci Sanitari Integral. Sant Joan Despí, Spain., Borrallo RM; Internal Medicine Department. Terrasa Hospital. Consorci Sanitari Terrassa, Spain., Miret M; LIPIDCAS, Endocrinology Department, Hospital Verge de la Cinta, Tortosa, Spain., Näf S; LIPIDCAS, Endocrinology Department, University Hospital Joan XXIII, IISPV. CIBERDEM. Universitat Rovira i Virgili. Tarragona, Spain., Pardo A; Internal Medicine Department, Hospital Delfos, Barcelona, Spain., Perea V; Lipid Unit, Hospital Mutua Terrasa, Barcelona, Spain., Pérez-Bernalte R; LIPIDCAS, Hospital del Vendrell, El Vendrell, Spain., Ramírez-Montesinos R; LIPIDCAS, Hospital Sant Pau i Santa Tecla, Tarragona, Spain., Royuela M; Lipid Unit, ALTHAIA, Xarxa Assistencial Universitària de Manresa, Spain., Soler C; Lipid Unit, Hospital Santa Caterina, Girona, Spain., Urquizu-Padilla M; Lipid Unit, University Hospital Vall d'Hebron, Barcelona Autonomous University, Barcelona, Spain., Zamora A; Lipid Unit, Corporació de Salut del Maresme i la Selva, Hospital de Blanes, Spain., Pedro-Botet J; Lipid Unit, University Hospital del Mar, Barcelona Autonomous University, Barcelona, Spain., Masana L; Universitat Rovira i Virgili, LIPIDCAS, University Hospital Sant Joan IISPV, CIBERDEM, Reus, Spain., Domingo JL; Universitat Rovira i Virgili, Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Sant Llorenç 21, 43201 Reus, Catalonia, Spain.

Publikováno v: Environment international [Environ Int] 2022 Jan; Vol. 158, pp. 106930. Date of Electronic Publication: 2021 Oct 16.

Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population.

Autor: Ascaso JF; Clinic-University Hospital, University of Valencia, Spain. ascaso@uv.es, Millán J, Mateo-Gallego R, Ruiz A, Suarez-Tembra M, Borrallo RM, Zambon D, Gonzalez-Santos P, Peres-de-Juan M, Ros E

Publikováno v: European journal of internal medicine [Eur J Intern Med] 2011 Apr; Vol. 22 (2), pp. 177-81. Date of Electronic Publication: 2011 Jan 14.